Daily News

Most Recent

Q&A: Leszek Borysiewicz

By | October 5, 2007

The new head of the UK's Medical Research Council discusses the challenges ahead


Calif. stem cell agency back on track?

By | October 4, 2007

Agency won't award two grants, and sells more bonds than expected in first public sale


Disputed stem cell patents amended

By | October 4, 2007

Changes to challenged stem cell patents are not a step-back from their claims, says WARF


No new Science chief until '08

By | October 3, 2007

AAAS's search committee doesn't plan to get going until next year


Vote now for the Best Places to Work as a Postdoc

By | October 1, 2007

Your thoughts about your workplace will help us rank the best postdoc institutions around the world


Fascinating Bohr

By | September 28, 2007

The physicist (and Einstein's esteemed colleague and sometime intellectual opponent) Niels Bohr gave biologists a new conceptual tool


MRC confirms new chief

By | September 28, 2007

Imperial College vaccinologist to head UK biomedical research


Yin, meet yang

By | September 28, 2007

As a molecular biologist who holds a PhD in comparative literature, Priya Venkatesan offers a unique perspective on why sciences and humanities often don't get along


Hair yields ancient DNA

By | September 27, 2007

Researchers extract complete mitochondrial genomes from mammoth coat-hair shafts

1 Comment

Help women stay in science

By | September 27, 2007

Add your thoughts to the growing discussion on the role men should play in helping women stay in science


Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham